Overall tolerabilityReported
Both formulae were well accepted without differences in tolerance or occurrence of adverse events.
from: Suitability and safety of L-5-methyltetrahydrofolate as a folate source in infant formula:common coldReported
The most common adverse events were common cold, poor weight gain or growth, rash, eczema, or dry skin and respiratory tract infection.
from: Suitability and safety of L-5-methyltetrahydrofolate as a folate source in infant formula:dry skinReported
The most common adverse events were common cold, poor weight gain or growth, rash, eczema, or dry skin and respiratory tract infection.
from: Suitability and safety of L-5-methyltetrahydrofolate as a folate source in infant formula:eczemaReported
The most common adverse events were common cold, poor weight gain or growth, rash, eczema, or dry skin and respiratory tract infection.
from: Suitability and safety of L-5-methyltetrahydrofolate as a folate source in infant formula:poor weight gain or growthReported
The most common adverse events were common cold, poor weight gain or growth, rash, eczema, or dry skin and respiratory tract infection.
from: Suitability and safety of L-5-methyltetrahydrofolate as a folate source in infant formula:rashReported
The most common adverse events were common cold, poor weight gain or growth, rash, eczema, or dry skin and respiratory tract infection.
from: Suitability and safety of L-5-methyltetrahydrofolate as a folate source in infant formula:respiratory tract infectionReported
The most common adverse events were common cold, poor weight gain or growth, rash, eczema, or dry skin and respiratory tract infection.
from: Suitability and safety of L-5-methyltetrahydrofolate as a folate source in infant formula: